Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDA

by Pelican Press
0 minutes read

Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDA

Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDA
The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease.



Source link

#Decision #Eli #Lillys #Alzheimers #drug #delayed #U.S #FDA

You may also like